$ALOT
AstroNova, Inc.

2014 Q4 Form 10-Q Financial Statement

#000119312514438922 Filed on December 10, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q1 2013 Q4
Revenue $23.14M $17.73M $18.18M
YoY Change 27.27% 9.51% 13.34%
Cost Of Revenue $12.99M $10.14M $10.82M
YoY Change 20.05% 1.4% 13.2%
Gross Profit $10.15M $7.590M $7.363M
YoY Change 37.88% 22.62% 13.56%
Gross Profit Margin 43.88% 42.81% 40.5%
Selling, General & Admin $6.013M $5.950M $4.950M
YoY Change 21.47% 34.92% 12.86%
% of Gross Profit 59.23% 78.39% 67.23%
Research & Development $1.564M $1.460M $1.230M
YoY Change 27.15% 39.05% 37.12%
% of Gross Profit 15.41% 19.24% 16.71%
Depreciation & Amortization $500.0K $330.0K $310.0K
YoY Change 61.29% -2.94% 3.33%
% of Gross Profit 4.93% 4.35% 4.21%
Operating Expenses $7.577M $7.410M $6.180M
YoY Change 22.61% 35.96% 16.98%
Operating Profit $2.575M $180.0K $1.183M
YoY Change 117.67% -75.68% -1.5%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$46.00K -$60.00K -$2.000K
YoY Change 2200.0% 50.0% -104.26%
Pretax Income $2.529M $130.0K $1.181M
YoY Change 114.14% -82.67% -5.37%
Income Tax $974.0K -$270.0K $436.0K
% Of Pretax Income 38.51% -207.69% 36.92%
Net Earnings $1.555M $1.860M $1.108M
YoY Change 40.34% -75.65% -15.23%
Net Earnings / Revenue 6.72% 10.49% 6.09%
Basic Earnings Per Share $0.20 $0.15
Diluted Earnings Per Share $0.20 $237.2K $0.14
COMMON SHARES
Basic Shares Outstanding 7.730M shares 7.605M shares 7.490M shares
Diluted Shares Outstanding 7.926M shares 7.716M shares

Balance Sheet

Concept 2014 Q4 2014 Q1 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.90M $27.10M $32.60M
YoY Change -5.21% -31.39% 41.74%
Cash & Equivalents $13.27M $8.341M $12.97M
Short-Term Investments $17.60M $18.80M $19.70M
Other Short-Term Assets $7.500M $10.90M $12.50M
YoY Change -40.0% 14.74% 278.79%
Inventory $16.42M $15.18M $11.92M
Prepaid Expenses
Receivables $13.77M $11.37M $10.97M
Other Receivables $400.0K $500.0K $500.0K
Total Short-Term Assets $69.01M $65.03M $68.58M
YoY Change 0.62% -7.26% 29.65%
LONG-TERM ASSETS
Property, Plant & Equipment $8.265M $7.592M $7.723M
YoY Change 7.02% -2.52% -27.82%
Goodwill $991.0K $991.0K $795.0K
YoY Change 24.65% 24.65%
Intangibles $2.873M $3.400M
YoY Change
Long-Term Investments
YoY Change
Other Assets $400.0K $5.338M $100.0K
YoY Change 300.0% 967.6% 0.0%
Total Long-Term Assets $4.478M $5.338M $1.462M
YoY Change 206.29% 166.5% -89.56%
TOTAL ASSETS
Total Short-Term Assets $69.01M $65.03M $68.58M
Total Long-Term Assets $4.478M $5.338M $1.462M
Total Assets $81.75M $77.96M $77.77M
YoY Change 5.12% -2.44% 16.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.432M $2.374M $2.750M
YoY Change 61.16% 22.5% 25.0%
Accrued Expenses $5.500M $2.310M $6.300M
YoY Change -12.7% -63.33% 43.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.57M $9.892M $11.70M
YoY Change -9.66% -26.86% 55.99%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $300.0K $0.00
YoY Change
Other Long-Term Liabilities $1.000M $1.100M $1.300M
YoY Change -23.08% -54.17% 62.5%
Total Long-Term Liabilities $1.000M $1.400M $1.300M
YoY Change -23.08% -41.67% 62.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.57M $9.892M $11.70M
Total Long-Term Liabilities $1.000M $1.400M $1.300M
Total Liabilities $11.66M $11.35M $13.21M
YoY Change -11.78% -29.4% 29.54%
SHAREHOLDERS EQUITY
Retained Earnings $39.70M $37.20M $35.88M
YoY Change 10.65% 3.07%
Common Stock $476.0K $465.0K $461.0K
YoY Change 3.25% 2.88%
Preferred Stock
YoY Change
Treasury Stock (at cost) $13.09M $12.46M $12.35M
YoY Change 6.02% 6.83%
Treasury Stock Shares 1.776M shares 1.730M shares 1.721M shares
Shareholders Equity $70.10M $66.61M $64.56M
YoY Change
Total Liabilities & Shareholders Equity $81.75M $77.96M $77.77M
YoY Change 5.12% -2.44% 16.25%

Cashflow Statement

Concept 2014 Q4 2014 Q1 2013 Q4
OPERATING ACTIVITIES
Net Income $1.555M $1.860M $1.108M
YoY Change 40.34% -75.65% -15.23%
Depreciation, Depletion And Amortization $500.0K $330.0K $310.0K
YoY Change 61.29% -2.94% 3.33%
Cash From Operating Activities $4.440M $530.0K $1.200M
YoY Change 270.0% -36.14% -37.5%
INVESTING ACTIVITIES
Capital Expenditures -$850.0K -$220.0K -$540.0K
YoY Change 57.41% -31.25% 157.14%
Acquisitions
YoY Change
Other Investing Activities -$2.750M -$5.470M $580.0K
YoY Change -574.14% -133.21% -81.82%
Cash From Investing Activities -$3.590M -$5.690M $40.00K
YoY Change -9075.0% -135.23% -98.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -490.0K 10.00K -450.0K
YoY Change 8.89% -101.32% -64.57%
NET CHANGE
Cash From Operating Activities 4.440M 530.0K 1.200M
Cash From Investing Activities -3.590M -5.690M 40.00K
Cash From Financing Activities -490.0K 10.00K -450.0K
Net Change In Cash 360.0K -5.150M 790.0K
YoY Change -54.43% -131.75% -78.24%
FREE CASH FLOW
Cash From Operating Activities $4.440M $530.0K $1.200M
Capital Expenditures -$850.0K -$220.0K -$540.0K
Free Cash Flow $5.290M $750.0K $1.740M
YoY Change 204.02% -34.78% -18.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12974000
CY2012Q1 alot Debt Received Upon Sale Of Operation
DebtReceivedUponSaleOfOperation
1000000
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7239496 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9513370 shares
CY2014Q4 us-gaap Loans Receivable Basis Spread On Variable Rate
LoansReceivableBasisSpreadOnVariableRate
0.02 pure
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
9.70
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.84
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
449493 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.62
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1776121 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
72245 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
693067 shares
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3599000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28275000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10569000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
476000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-180000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4432000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39700000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
39000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
70096000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2253000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81753000
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
43191000
CY2014Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1007000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
492000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
650000
CY2014Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
113000
CY2014Q4 us-gaap Liabilities
Liabilities
11657000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3279000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13272000
CY2014Q4 us-gaap Goodwill
Goodwill
991000
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10671000
CY2014Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
250000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8265000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2485570
CY2014Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
23585000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3666000
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
270000
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7859000
CY2014Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
253000
CY2014Q4 us-gaap Notes Receivable Net
NotesReceivableNet
503000
CY2014Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
4478000
CY2014Q4 us-gaap Other Assets
OtherAssets
91000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36540000
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2088870
CY2014Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Current
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
2120000
CY2014Q4 us-gaap Assets
Assets
81753000
CY2014Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
5954000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1701000
CY2014Q4 us-gaap Inventory Gross
InventoryGross
20023000
CY2014Q4 us-gaap Inventory Net
InventoryNet
16424000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13766000
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
17631000
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2873000
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1493000
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
13091000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
69010000
CY2014Q4 alot Revolving Line Of Credit Facility Issued Maximum Capacity
RevolvingLineOfCreditFacilityIssuedMaximumCapacity
600000
CY2014Q4 alot Product Replacement Reserve
ProductReplacementReserve
402000
CY2014Q4 alot Product Replacement Cost Charged Against Reserve
ProductReplacementCostChargedAgainstReserve
271000
CY2014Q4 alot Revolving Line Of Credit Facility Issued Amount Outstanding
RevolvingLineOfCreditFacilityIssuedAmountOutstanding
180000
CY2014Q4 alot Contract Related To Noncompete Agreement
ContractRelatedToNoncompeteAgreement
42000
CY2014Q4 alot Line Of Credit Receivable Current
LineOfCreditReceivableCurrent
180000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30999000
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9291225 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
9.12
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.63
CY2014Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1730042 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
106496 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
736647 shares
CY2014Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3194000
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27368000
CY2014Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
836000
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9892000
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
465000
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
176000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2374000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
37201000
CY2014Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
77000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
66614000
CY2014Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2310000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77964000
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
41235000
CY2014Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1131000
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
454000
CY2014Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
715000
CY2014Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
788000
CY2014Q1 us-gaap Liabilities
Liabilities
11350000
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3130000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8341000
CY2014Q1 us-gaap Goodwill
Goodwill
991000
CY2014Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
10722000
CY2014Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
250000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7592000
CY2014Q1 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
23500000
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1383000
CY2014Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1800000
CY2014Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
313000
CY2014Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6798000
CY2014Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
440000
CY2014Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
5338000
CY2014Q1 us-gaap Other Assets
OtherAssets
194000
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34960000
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3707000
CY2014Q1 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Current
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
2120000
CY2014Q1 us-gaap Assets
Assets
77964000
CY2014Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
4734000
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1673000
CY2014Q1 us-gaap Inventory Gross
InventoryGross
18372000
CY2014Q1 us-gaap Inventory Net
InventoryNet
15178000
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11366000
CY2014Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
3917000
CY2014Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
18766000
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3400000
CY2014Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
852000
CY2014Q1 us-gaap Treasury Stock Value
TreasuryStockValue
12463000
CY2014Q1 us-gaap Assets Current
AssetsCurrent
65034000
CY2014Q1 alot Contract Related To Noncompete Agreement
ContractRelatedToNoncompeteAgreement
250000
CY2014Q1 alot Line Of Credit Receivable Current
LineOfCreditReceivableCurrent
240000
CY2012Q1 alot Loan Receivable Interest Rate Stated Percentage
LoanReceivableInterestRateStatedPercentage
0.0375 pure
CY2013Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
18600000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
172100 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
5834 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.56
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
ASTRO MED INC /NEW/
dei Trading Symbol
TradingSymbol
ALOT
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
219310 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.352 pure
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b>(1) Overview</b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Headquartered in West Warwick, Rhode Island, Astro-Med Inc. designs, develops, manufactures and distributes a broad range of specialty printers and data acquisition and analysis systems. Our products are distributed through our own sales force and authorized dealers in the United States. We also sell to customers outside of the United States primarily through our Company offices in Canada and Europe as well as with independent dealers and representatives. Astro-Med, Inc. products are sold under the brand names Astro-Med&#xA0;<sup style="FONT-SIZE: 11px; VERTICAL-ALIGN: top">&#xAE;</sup>&#xA0;Test&#xA0;&amp; Measurement and QuickLabel&#xA0;<sup style="FONT-SIZE: 11px; VERTICAL-ALIGN: top">&#xAE;</sup>Systems and are employed around the world in a wide range of aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation applications.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> Unless otherwise indicated, references to &#x201C;Astro-Med,&#x201D; the &#x201C;Company,&#x201D; &#x201C;we,&#x201D; &#x201C;our,&#x201D; and &#x201C;us&#x201D; in this Quarterly Report on Form&#xA0;10-Q refer to Astro-Med, Inc. and its consolidated subsidiaries.</p> </div>
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1784000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.80
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
35662 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.020 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
155600 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
7245 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016 pure
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
2464 shares
dei Document Period End Date
DocumentPeriodEndDate
2014-11-01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
8.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
10.07
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7897061 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.54
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y2M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
10787 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.98
dei Entity Central Index Key
EntityCentralIndexKey
0000008146
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.268 pure
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
155000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
188393 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7677751 shares
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
9462000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-348000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1223000
us-gaap Gross Profit
GrossProfit
28376000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3602000
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-356000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-356000
us-gaap Sales Revenue Net
SalesRevenueNet
66277000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1245000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6353000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1619000
us-gaap Operating Income Loss
OperatingIncomeLoss
6438000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3762000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-85000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4118000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1719000
us-gaap Net Income Loss
NetIncomeLoss
4118000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2400000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-8000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1541000
us-gaap Operating Expenses
OperatingExpenses
21938000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4414000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13483000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1349000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4931000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2235000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3807000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
1800000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
37901000
us-gaap Decrease In Restricted Cash
DecreaseInRestrictedCash
1800000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-660000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
381000
us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4041000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1984000
alot Loan Receivable Date Considered For Interest Payments
LoanReceivableDateConsideredForInterestPayments
2013-01-30
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
959000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
10585000
us-gaap Share Based Compensation
ShareBasedCompensation
381000
us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
80000
alot Non Employee Director Received Restricted Stock Award Value
NonEmployeeDirectorReceivedRestrictedStockAwardValue
20000
alot Fees To Non Employee Director
FeesToNonEmployeeDirector
7000
alot Line Of Credit Issued Initial Term
LineOfCreditIssuedInitialTerm
P1Y
alot Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
1 Equity_Plan
alot Product Replacement Related Costs
ProductReplacementRelatedCosts
alot Agreement Expiration Date
AgreementExpirationDate
2014-01-31
alot Transition Services Period Maximum
TransitionServicesPeriodMaximum
P12M
alot Maximum Disposal Restriction As Percentage Of Restricted Stock Units
MaximumDisposalRestrictionAsPercentageOfRestrictedStockUnits
0.50 pure
alot Number Of Installments
NumberOfInstallments
16 Installment
alot Period To Receive Lower Product Prices From Supplier
PeriodToReceiveLowerProductPricesFromSupplier
P3Y
alot Reservation Of Shares Under Employee Stock Purchase Plan
ReservationOfSharesUnderEmployeeStockPurchasePlan
247500 shares
alot Discontinued Operations Amount Received From Disposition Of Inventory
DiscontinuedOperationsAmountReceivedFromDispositionOfInventory
-2355000
alot Payments Received On Line Of Credit And Note Receivable
PaymentsReceivedOnLineOfCreditAndNoteReceivable
248000
alot Revolving Line Of Credit Facility Issued Maturity Date
RevolvingLineOfCreditFacilityIssuedMaturityDate
2015-01-31
alot Income Tax Benefit From Expiration Of Statutes Of Limitation
IncomeTaxBenefitFromExpirationOfStatutesOfLimitation
141000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
200763 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.347 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4994000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.026 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.11
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.008 pure
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
3152 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.07
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7650014 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.11
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.21
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.383 pure
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7449251 shares
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
19056000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-56000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-362000
us-gaap Gross Profit
GrossProfit
19390000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4881000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-38000
us-gaap Sales Revenue Net
SalesRevenueNet
50858000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1039000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1284000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1569000
us-gaap Operating Income Loss
OperatingIncomeLoss
1348000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1317000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-64000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
6201000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
517000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
838000
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
668000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
910000
us-gaap Net Income Loss
NetIncomeLoss
1355000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3368000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
18000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
192000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
951000
us-gaap Operating Expenses
OperatingExpenses
18042000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3617000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10680000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-4940000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-18025000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
446000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12026000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
30796000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1005000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
406000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3745000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1087000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
564000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
7940000
us-gaap Share Based Compensation
ShareBasedCompensation
406000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
333000
us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-18000
alot Product Replacement Related Costs
ProductReplacementRelatedCosts
672000
alot Income Tax Expense
IncomeTaxExpense
464000
CY2014Q1 alot Settlement Amount Received From Supplier For Recovery Of Cost And Expenses
SettlementAmountReceivedFromSupplierForRecoveryOfCostAndExpenses
450000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M12D
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.79
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2013Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
226130 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.00
CY2013Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.369 pure
CY2013Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.10
CY2013Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.05
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7715820 shares
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2013Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.10
CY2013Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2013Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.04
CY2013Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
131600 shares
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7489690 shares
CY2013Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
137000
CY2013Q4 us-gaap Gross Profit
GrossProfit
7363000
CY2013Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
151000
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
18179000
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1181000
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1183000
CY2013Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1259000
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2000
CY2013Q4 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
2485000
CY2013Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
363000
CY2013Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
745000
CY2013Q4 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
290000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
1108000
CY2013Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
6180000
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1230000
CY2013Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3727000
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
436000
CY2013Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
10816000
CY2013Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
127000
CY2013Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1223000
CY2013Q4 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-89000
CY2013Q4 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-18000
CY2013Q4 alot Product Replacement Related Costs
ProductReplacementRelatedCosts
CY2014Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2014Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
155000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.93
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2014Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
196620 shares
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7729530 shares
CY2014Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-307000
CY2014Q4 us-gaap Gross Profit
GrossProfit
10152000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.84
CY2014Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-313000
CY2014Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.385 pure
CY2014Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.20
CY2014Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7926150 shares
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2014Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.20
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
23137000
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2529000
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
2575000
CY2014Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1242000
CY2014Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-46000
CY2014Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1555000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
1555000
CY2014Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6000
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
7577000
CY2014Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1564000
CY2014Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4606000
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
974000
CY2014Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
12985000
CY2014Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
122000
CY2014Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1407000
CY2014Q4 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
80000
CY2014Q4 alot Developments Affecting Unrecognized Tax Benefits
DevelopmentsAffectingUnrecognizedTaxBenefits
0
CY2014Q4 alot Product Replacement Related Costs
ProductReplacementRelatedCosts
CY2014Q4 alot Income Tax Benefit From Expiration Of Statutes Of Limitation
IncomeTaxBenefitFromExpirationOfStatutesOfLimitation
41000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.43
CY2014Q2 alot Discontinued Operations Amount Received From Disposition Of Inventory
DiscontinuedOperationsAmountReceivedFromDispositionOfInventory
2355000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.79

Files In Submission

Name View Source Status
0001193125-14-438922-index-headers.html Edgar Link pending
0001193125-14-438922-index.html Edgar Link pending
0001193125-14-438922.txt Edgar Link pending
0001193125-14-438922-xbrl.zip Edgar Link pending
alot-20141101.xml Edgar Link completed
alot-20141101.xsd Edgar Link pending
alot-20141101_cal.xml Edgar Link unprocessable
alot-20141101_def.xml Edgar Link unprocessable
alot-20141101_lab.xml Edgar Link unprocessable
alot-20141101_pre.xml Edgar Link unprocessable
d819863d10q.htm Edgar Link pending
d819863dex1012.htm Edgar Link pending
d819863dex311.htm Edgar Link pending
d819863dex312.htm Edgar Link pending
d819863dex321.htm Edgar Link pending
d819863dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending